M&A Deal Summary

Eliem Therapeutics Acquires Tenet Medicines

On April 11, 2024, Eliem Therapeutics acquired life science company Tenet Medicines

Acquisition Highlights
  • This is Eliem Therapeutics’ 1st transaction in the Life Science sector.
  • This is Eliem Therapeutics’ 1st transaction in the United States.
  • This is Eliem Therapeutics’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2024-04-11
Target Tenet Medicines
Sector Life Science
Buyer(s) Eliem Therapeutics
Deal Type Add-on Acquisition
Advisor(s) Cooley LLP (Legal)

Target

Tenet Medicines

Scotch Plains, New Jersey, United States
Tenet Medicines is a biopharmaceutical company focused on developing therapeutics for autoimmune driven inflammatory diseases. Tenet Medicines was founded in 2023 and is based in Scotch Plains, New Jersey.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Eliem Therapeutics

Redmond, Washington, United States

website

Category Company
Sector Life Science
DESCRIPTION

Eliem Therapeutics is a biotech company developing drugs for neurological disorders. Eliem Therapeutics is based in Redmond, Washington.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal